Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aquestive Therapeutics Inc (NQ: AQST )

5.030 -0.260 (-4.91%)
Streaming Delayed Price Updated: 12:29 PM EST, Mar 2, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Aquestive Therapeutics Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags AQST XENE FGEN
From Benzinga
Pomerantz Law Firm Announces the Filing of a Class Action against Aquestive Therapeutics, Inc. and Certain Officers - AQST
Pomerantz LLP announces that a class action lawsuit has been filed against Aquestive Therapeutics, Inc. ("Aquestive" or the "Company") (NASDAQ: AQST) and certain of its officers. The class action,... 
From PR Newswire
Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates
Most Food and Drug Administration decisions scheduled for February were positive, and more importantly five new molecular entities ... 
Tags PCRX News ZEAL
From Benzinga
The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and ... 
Tags BOLT Penny Stocks TERN
From Benzinga
Analysts Expect 11% Gains Ahead For IWO
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Aquestive Sees Libervant Application Resubmission By End Of Q2
TheFDA has provided further guidancetoAquestive Therapeutics Inc(NASDAQ:AQST) regarding the information ... 
Tags Benzinga Market News FDA
From Benzinga
Aquestive Therapeutics Reaffirms Near-Term NDA Resubmission for Libervant™ (diazepam) Buccal Film Following FDA Feedback
From GlobeNewswire News Releases
Aquestive Therapeutics to Announce Fourth Quarter and Year End 2020 Financial Results and Recent Business Highlights on March 9 and Host Conference Call on March 10 at 8:00 a.m. ET
From GlobeNewswire News Releases
Notable Two Hundred Day Moving Average Cross - AQST
In trading on Tuesday, shares of Aquestive Therapeutics Inc (AQST) crossed below their 200 day moving average of $5.95, changing hands as low as $5.91 per share. Aquestive Therapeutics Inc shares are... 
Tags Stocks
From Market News Video
Aquestive Therapeutics Strengthens Board of Directors with Appointments of Julie Krop, M.D., and Marco Taglietti, M.D., and Announces Resignation of Douglas K. Bratton from Board of Directors
From GlobeNewswire News Releases
Aquestive Therapeutics Appoints Mark Lepore, MD, as Chief Medical Officer for Allergy
From GlobeNewswire News Releases
Mitsubishi Tanabe Pharma America and Aquestive Therapeutics Announce U.S. Licensing and Supply Deal for Riluzole Oral Film for ALS Treatment
Mitsubishi Tanabe Pharma America, Inc. (MTPA) and Aquestive Therapeutics, Inc. (NASDAQ: AQST) today announced a licensing and supply deal for the U.S. rights to commercialize EXSERVAN™ (riluzole), an... 
From PR Newswire
Aquestive Therapeutics Provides Business Update
From GlobeNewswire News Releases
Aquestive Therapeutics to Present at Two Upcoming Investor Conferences
From GlobeNewswire News Releases
Interesting AQST Put And Call Options For August 2021
Investors in Aquestive Therapeutics Inc (AQST) saw new options become available this week, for the August 2021 expiration. One of the key inputs that goes into the price an option buyer is willing to... 
Tags Stocks
From Market News Video
Aquestive Therapeutics Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer
From GlobeNewswire News Releases
How The Pieces Add Up: DWAS Headed For $80
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Aquestive Therapeutics to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference
From GlobeNewswire News Releases
Aquestive Therapeutics Receives First Milestone Payment from KYNMOBI™ Monetization
Receives first milestone payment of $10 million, bringing total fourth quarter proceeds to $50 million 
From GlobeNewswire News Releases
68 Biggest Movers From Yesterday
Gainers Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) gained 157.9% to close at $49.00 after the company priced its IPO at $19 per ... 
Tags SCYX Markets AYRO
From Benzinga
Why Aquestive Therapeutics Stock Is Trading Higher Today
Aquestive Therapeutics (NASDAQ: AQST) shares are trading higher on Thursday after the company announced the completion of a Type A ... 
Tags Benzinga AQST why it's moving
From Benzinga
12 Healthcare Stocks Moving In Thursday's Intraday Session
Gainers Titan Pharmaceuticals (NASDAQ:TTNP) stock increased by 37.5% to $0.17 during Thursday's regular session. As ... 
Tags BLI KTRA Top Gainers
From Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
Gainers Naked Brand Group Limited (NASDAQ: NAKD) shares jumped 77.7% to $0.2302 after jumping around 47% on Wednesday. Phoenix ... 
Tags AKBA KTRA ZTO
From Benzinga
The Daily Biotech Pulse: Aquestive's Positive FDA Meeting, Prevail Awarded Patent, Neuro-Oncology Conference Gets Underway
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags KZIA News PCRX
From Benzinga
34 Stocks Moving in Thursday's Pre-Market Session
Gainers Hudson Capital Inc. (NASDAQ: HUSN) shares rose 44.2% to $3.23 in pre-market trading. Hudson Capital, on Monday, said it ... 
Tags Movers SONO Small Cap
From Benzinga
8 Stocks Moving In Wednesday's After-Hours Session
Gainers Corcept Therapeutics (NASDAQ: CORT) shares are trading higher after as traders circulate a November 18 USPTO court ... 
Tags SONO AQST News
From Benzinga
12 Healthcare Stocks Moving In Wednesday's After-Market Session
Gainers Corcept Therapeutics (NASDAQ:CORT) shares rose 22.99% to $22.95 during Wednesday's after-market session. At the close, ... 
Tags ORTX Movers RGLS
From Benzinga
Aquestive Therapeutics Completes FDA Type A Meeting on Libervant
From GlobeNewswire News Releases
54 Stocks Moving In Friday's Mid-Day Session
Gainers Urovant Sciences Ltd. (NASDAQ: UROV) shares climbed 94% to $16.06 after the company late Thursday announced Sumitovant ... 
Tags Intraday Update Trading Ideas Penny Stocks
From Benzinga
How The Parts Add Up: DWAS Headed For $75
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.